Log in

NYSE:MCRNMilacron Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
$16.80
0.00 (0.00 %)
(As of 11/22/2019)
Add
Compare
Today's Range
$16.80
Now: $16.80
$16.80
50-Day Range
$16.80
MA: $16.80
$16.80
52-Week Range
$11.11
Now: $16.80
$17.39
VolumeN/A
Average Volume735,324 shs
Market Capitalization$1.18 billion
P/E Ratio9.44
Dividend YieldN/A
Beta1.79
Milacron Holdings Corp. manufactures, distributes, and services engineered and customized systems within the plastic technology and processing industry in the United States and internationally. The company operates through three segments: Advanced Plastic Processing Technologies (APPT), Melt Delivery and Control Systems (MDCS), and Fluid Technologies (Fluids). The APPT segment designs, manufactures, and sells plastic processing equipment and systems, which include injection molding, blow molding, and extrusion equipment; and auxiliary systems and related parts and services. This segment serves companies who serve in the consumer goods, packaging, electronics, medical, automotive, and construction end markets. The MDCS segment designs, manufactures, and sells hot runner systems, process control systems, mold bases and components, and aftermarket parts and related technologies and services for injection molding, as well as maintenance, repair, and operating supplies for plastic processing operations. This segment serves customers in the plastic processing value chain and manufacturing spectrum, including OEMs, molders, and mold makers in the consumer goods, electronics, automotive, packaging, and medical end markets. The Fluids segment manufactures and markets coolants, lubricants, process cleaners, and corrosion inhibitors that are used in metalworking processes, such as cutting, grinding, stamping, forming, and high speed machining. This segment's products are used in various markets, such as aerospace, medical, automotive, industrial components and machinery, bearings, munitions, packaging, job shops, and glass and mirror production. The company was formerly known as Milacron LLC and changed its name to Milacron Holdings Corp. in May 2012. The company was founded in 1860 and is headquartered in Cincinnati, Ohio.
Read More
Milacron logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.0Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.20 out of 5 stars


Industry, Sector and Symbol

Industry Special industry machinery, not elsewhere classified
Sub-IndustryN/A
CUSIPN/A
Phone513-487-5000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.26 billion
Cash Flow$2.61 per share
Book Value$7.51 per share

Profitability

Net Income$41.50 million

Miscellaneous

Employees5,797
Market Cap$1.18 billion
Next Earnings DateN/A
OptionableOptionable

Receive MCRN News and Ratings via Email

Sign-up to receive the latest news and ratings for MCRN and its competitors with MarketBeat's FREE daily newsletter.

Milacron (NYSE:MCRN) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Milacron?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Milacron in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Milacron.

How were Milacron's earnings last quarter?

Milacron Holdings Corp (NYSE:MCRN) announced its quarterly earnings results on Tuesday, November, 12th. The industrial products company reported $0.34 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.35 by $0.01. The industrial products company had revenue of $250.30 million for the quarter, compared to analysts' expectations of $287 million. Milacron had a net margin of 3.25% and a return on equity of 19.22%. Milacron's quarterly revenue was down 11.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.40 EPS. View Milacron's earnings history.

What price target have analysts set for MCRN?

2 brokerages have issued 12 month price objectives for Milacron's stock. Their forecasts range from $17.00 to $17.00. On average, they expect Milacron's stock price to reach $17.00 in the next year. This suggests a possible upside of 1.2% from the stock's current price. View analysts' price targets for Milacron.

Has Milacron been receiving favorable news coverage?

News articles about MCRN stock have been trending somewhat negative this week, according to InfoTrie Sentiment Analysis. The research group identifies positive and negative press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Milacron earned a coverage optimism score of -1.2 on InfoTrie's scale. They also gave media stories about the industrial products company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the next few days. View the latest news about Milacron.

Who are some of Milacron's key competitors?

What other stocks do shareholders of Milacron own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Milacron investors own include Honeywell International (HON), Alibaba Group (BABA), CVS Health (CVS), Walt Disney (DIS), Home Depot (HD), Cisco Systems (CSCO), Procter & Gamble (PG), Thermo Fisher Scientific (TMO), CSX (CSX) and Ford Motor (F).

Who are Milacron's key executives?

Milacron's management team includes the following people:
  • Mr. Thomas J. Goeke, CEO, Pres & Director (Age 60)
  • Mr. Bruce A. Chalmers, Chief Financial Officer (Age 53)
  • Mr. Mark Scott Miller, VP & Chief HR Officer (Age 56)
  • Ms. Ling An-Heid, Pres of Mold-Masters (Age 58)
  • Mr. Gerrit Jue, Pres of Fluids (Age 60)

When did Milacron IPO?

(MCRN) raised $300 million in an IPO on Thursday, June 25th 2015. The company issued 14,300,000 shares at a price of $20.00-$22.00 per share. BofA Merrill Lynch, Barclays, J.P. Morgan, Baird, Credit Suisse and Goldman Sachs acted as the underwriters for the IPO and KeyBanc Capital Markets and William Blair were co-managers.

What is Milacron's stock symbol?

Milacron trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCRN."

What is Milacron's stock price today?

One share of MCRN stock can currently be purchased for approximately $16.80.

How big of a company is Milacron?

Milacron has a market capitalization of $1.18 billion and generates $1.26 billion in revenue each year. The industrial products company earns $41.50 million in net income (profit) each year or $1.78 on an earnings per share basis. Milacron employs 5,797 workers across the globe.

What is Milacron's official website?

The official website for Milacron is www.milacron.com.

How can I contact Milacron?

Milacron's mailing address is 10200 ALLIANCE ROAD SUITE 200, CINCINNATI OH, 45242. The industrial products company can be reached via phone at 513-487-5000 or via email at [email protected]

This page was last updated on 7/11/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.